SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-006705
Filing Date
2021-03-24
Accepted
2021-03-24 16:01:42
Documents
74
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1573209
2 ex21.htm EX-21 3319
3 ex23-1.htm EX-23.1 3300
4 ex31-1.htm EX-31.1 15647
5 ex31-2.htm EX-31.2 16068
6 ex32.htm EX-32 11703
7 form10-k_001.jpg GRAPHIC 25958
  Complete submission text file 0001493152-21-006705.txt   6428178

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE abeo-20201231.xsd EX-101.SCH 43742
9 XBRL CALCULATION FILE abeo-20201231_cal.xml EX-101.CAL 62984
10 XBRL DEFINITION FILE abeo-20201231_def.xml EX-101.DEF 200797
11 XBRL LABEL FILE abeo-20201231_lab.xml EX-101.LAB 383081
12 XBRL PRESENTATION FILE abeo-20201231_pre.xml EX-101.PRE 310848
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 933611
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 21768232
SIC: 2834 Pharmaceutical Preparations